These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 23993279)

  • 1. The global burden of drug use and mental disorders.
    Lynskey MT; Strang J
    Lancet; 2013 Nov; 382(9904):1540-2. PubMed ID: 23993279
    [No Abstract]   [Full Text] [Related]  

  • 2. Developing accuracy when estimating Global Burden of Disease (GBD) in mental and substance use disorders using complex research methodology, refined data analysis and community participation.
    Yearwood EL
    Evid Based Ment Health; 2014 Nov; 17(4):105. PubMed ID: 24667733
    [No Abstract]   [Full Text] [Related]  

  • 3. Global Burden Of Disease Studies: Implications For Mental And Substance Use Disorders.
    Whiteford H; Ferrari A; Degenhardt L
    Health Aff (Millwood); 2016 Jun; 35(6):1114-20. PubMed ID: 27269030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How did we arrive at burden of disease estimates for mental and illicit drug use disorders in the Global Burden of Disease Study 2010?
    Whiteford HA; Ferrari AJ; Baxter AJ; Charlson FJ; Degenhardt L
    Curr Opin Psychiatry; 2013 Jul; 26(4):376-83. PubMed ID: 23689547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of mental and substance use disorders in Indigenous Australians and Oceania.
    Charlson FJ; Erskine HE
    Australas Psychiatry; 2015 Dec; 23(6 Suppl):13-6. PubMed ID: 26634661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: improving the mental health and substance use estimates in the Global Burden of Disease study: strengthening the evidence base for public policy.
    Whiteford HA; Degenhardt L; Murray CJ; Vos T; Lopez AD
    Int J Epidemiol; 2014 Apr; 43(2):296-301. PubMed ID: 24639446
    [No Abstract]   [Full Text] [Related]  

  • 7. [Not Available].
    Krome S
    Gesundheitswesen; 2014 Apr; 76(4):181. PubMed ID: 24892181
    [No Abstract]   [Full Text] [Related]  

  • 8. Data watch. What is the cost of ADM (alcohol and drug abuse and mental health) in the U.S.?
    Behav Healthc Tomorrow; 1998 Apr; 7(2):18-9, 31. PubMed ID: 10178432
    [No Abstract]   [Full Text] [Related]  

  • 9. National and sub-national prevalence, trend, and burden of mental disorders and substance abuse in Iran: 1990 - 2013, study protocol.
    Naserbakht M; Djalalinia S; Tayefi B; Gholami M; Eftekhar Ardabili M; Shariat SV; Taban M; Hajebi A; Behtaj F; Sajadi SA; Rahimi-Movaghar A; Moradi-Lakeh M; Farzadfar F
    Arch Iran Med; 2014 Mar; 17(3):182-8. PubMed ID: 24621361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future Surveillance of Mental Disorders in the United States: Count People, Not Disorders.
    Merikangas KR; Bromet EJ; Druss BG
    JAMA Psychiatry; 2017 May; 74(5):431-432. PubMed ID: 28329225
    [No Abstract]   [Full Text] [Related]  

  • 11. Violence, mental health, substance abuse-problems for women worldwide.
    Wyshak G
    Health Care Women Int; 2000; 21(7):631-9. PubMed ID: 11813770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The burden of mental illness and addiction in ontario.
    Ratnasingham S; Cairney J; Manson H; Rehm J; Lin E; Kurdyak P
    Can J Psychiatry; 2013 Sep; 58(9):529-37. PubMed ID: 24099501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of mental disorders: a comparison of methods between the Australian burden of disease studies and the Global Burden of Disease study.
    Vos T; Mathers CD
    Bull World Health Organ; 2000; 78(4):427-38. PubMed ID: 10885161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The global distribution of mental and substance use disorders: research gains and challenges.
    Ferrari AJ
    Epidemiol Psychiatr Sci; 2016 Jun; 25(3):230-2. PubMed ID: 26687573
    [No Abstract]   [Full Text] [Related]  

  • 15. National Drug Abuse Survey shows drug use increasing, covers mental illness for the first time.
    Psychiatr Serv; 2002 Oct; 53(10):1342. PubMed ID: 12371427
    [No Abstract]   [Full Text] [Related]  

  • 16. The course and treatment of substance use disorder in persons with severe mental illness.
    Mueser KT; Drake RE; Miles KM
    NIDA Res Monogr; 1997; 172():86-109. PubMed ID: 9154267
    [No Abstract]   [Full Text] [Related]  

  • 17. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs.
    Jané-Llopis E; Matytsina I
    Drug Alcohol Rev; 2006 Nov; 25(6):515-36. PubMed ID: 17132571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the burden of disease attributable to illicit drug use and mental disorders: what is 'Global Burden of Disease 2005' and why does it matter?
    Degenhardt L; Whiteford H; Hall W; Vos T
    Addiction; 2009 Sep; 104(9):1466-71. PubMed ID: 19686517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The burden of mental, neurological, and substance use disorders in China and India: a systematic analysis of community representative epidemiological studies.
    Charlson FJ; Baxter AJ; Cheng HG; Shidhaye R; Whiteford HA
    Lancet; 2016 Jul; 388(10042):376-389. PubMed ID: 27209143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disability-adjusted Life Years (DALYs) for Mental and Substance Use Disorders in the Korean Burden of Disease Study 2012.
    Lim D; Lee WK; Park H
    J Korean Med Sci; 2016 Nov; 31 Suppl 2(Suppl 2):S191-S199. PubMed ID: 27775257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.